Xiaomin Wan, Xiaohui Zeng, Liubao Peng, Ye Peng, Qiao Liu, Lidan Yi, . . . Chongqing Tan. (2021). Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer. Frontiers Media S.A..
Chicago Style (17th ed.) CitationXiaomin Wan, et al. Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer. Frontiers Media S.A., 2021.
MLA (9th ed.) CitationXiaomin Wan, et al. Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer. Frontiers Media S.A., 2021.
Warning: These citations may not always be 100% accurate.